We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Repligen, MIT Sue ImClone Over Erbitux Patent

Law360 (May 5, 2004, 12:00 AM EDT) -- A drug maker and a university are suing Manhattan-based biotech company ImClone over patent rights to the drug at the center of the scandal that led to the trials of ImClone...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.